Biotechnology company
GLP-TOX studies ongoing
SLE, RA, Cancer efficacy studies ongoing
GB920 Joint Research
and Development
Agreement singed with PLATBIO
Series A Fundrasing closed: USD 10M
GB910/RA new use patent registered
sGal-9 Manufacturing process established
Venture Company Certification(제20190402684호)
GBIO Lab Foundation
sGal-9 new material patent(USA/Japan)
ownership acquired
Incorporation of GBIOLOGICS